Advertisement Pharmaceutical Business review - Page 3242 of 5286 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 17, 2026

EMA validates Pfizer and Valneva’s Lyme disease vaccine

The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) from Pfizer and Valneva for their Lyme disease vaccine candidate, PF-07307405.

Continue
In the VALOR clinical trial, PF-07307405 showed efficacy of over 70% in preventing Lyme disease. Credit: MrWinn / Shutterstock.com.
August 17, 2026

FDA grants fast track status to Phanes’ spevatamig for advanced BTC

Phanes has expanded a clinical trial partnership with MSD to study spevatamig with pembrolizumab for BTC. Credit: PeopleImages / Shutterstock.com.
August 14, 2026

BMS secures FDA accelerated approval for Zenbexus in multiple myeloma

Zenbexus is said to be the first CELMoD therapy approved by the FDA for multiple myeloma treatment. Credit: Bristol-Myers Squibb / Business Wire.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Xanadu and University of Alberta to develop quantum algorithms for cancer
  2. Akeso secures China NMPA authorisation for ivonescimab combo
  3. Remepy secures $36m funding for hybrid drug pipeline expansion
  4. Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat
  5. Alfasigma signs agreement to acquire Nordic Group

PRESS RELEASES

SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography